axicabtagene ciloleucel
gilead,daiichi sankyo
['axi-cel', 'lymsm']
real-world data consistent with patient-reported outcomes regarding axi-cel administration in relapsed/refractory lbcl #ash22 #lymsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.